NTRK2 and colorectal carcinoma: In conclusion, we have demonstrated that BDNF/TrkB signaling in tumor tissues is associated with tumor progression and poor prognosis in CRC patients, and that it is also associated with proliferation, migration, invasion, and anoikis resistance in BDNF/TrkB co-expressing CRC cells.